Benzinga - Wed, 14 Apr 2021 11:45:00 -0400
Benzinga - Sat, 27 Mar 2021 08:14:38 -0400
load more
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-26
REV
Q4 2020Est.ActualSurprise
EPS-0.240-0.070 0.1700
REV26.030M21.461M-4.569M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
RDHLRedhill Biopharma-1.12%330.4M

Redhill Biopharma Company Questions & Answers

Q

How do I buy Redhill Biopharma (RDHL) stock?

A

You can purchase shares of Redhill Biopharma (NASDAQ: RDHL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Redhill Biopharma's (RDHL) main competitors?

A

There are no as such competitors for Redhill Biopharma.

Q

What is the target price for Redhill Biopharma?

A

The latest price target for Redhill Biopharma (NASDAQ: RDHL) was reported by BTIG on 2020-09-11. The analyst firm set a price target for 26.00 expecting RDHL to rise to within 12 months (a possible 267.23% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Redhill Biopharma (RDHL) stock ?

A

The stock price for Redhill Biopharma (NASDAQ: RDHL) is $7.08 last updated Wed Apr 14 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Redhill Biopharma (RDHL) dividend?

A

There are no upcoming dividends for Redhill Biopharma.

Q

When is Redhill Biopharma (NASDAQ:RDHL) reporting earnings?

A
Redhill Biopharma’s Q1 earnings are confirmed after-market from now on May 26, 2021.
Q

When is the upcoming split for RDHL?

A

There is no upcoming split for Redhill Biopharma.